Results 51 to 60 of about 3,788,125 (317)

Parent Quality of Life at Two Years Following Their Child's Completion of Acute Lymphoblastic Leukemia Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Parents of children treated for acute lymphoblastic leukemia (ALL) often experience significant caregiver burden and disruption to their well‐being. While parent quality of life (QoL) during treatment is well characterized, little is known about outcomes during early survivorship.
Sara Dal Pra, Maria McCarthy, Michael Takagi, Cinzia De Luca   +3 more
wiley   +1 more source

Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)

Acta Neuropathologica Communications
Neurofibromatosis type 1 (NF1) is among the most common neurogenetic disorders and is associated with an increased risk of developing tumors in the nervous system.
Benjamin E Aghoghovwia, Cheng-En Shen, Sabiha Bano, Nandini Shyamala, Alesandra Echeandia Marrero, Khushboo Irshad, Samer Sharafaldin, Nicole M Brossier, Yuan Pan   +8 more
doaj   +1 more source

Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Cognitive and psychological difficulties could negatively interfere with treatment adherence and quality of life before and after hematopoietic stem cell transplant (HSCT). Methods to mitigate these changes may have positive effects on treatment success.
Kristen L. Votruba, Michelle Rozwadowski, Thomas Braun, April Rahrig, Edward Peres, Kirsten M. Williams, Vanessa Fabrizio, Julie‐An Talano, Carrie L. Kitko, Nicolas Parnell, Pavan Reddy, Sung Won Choi   +11 more
wiley   +1 more source

Functioning of post-COVID-19 patients: a cross-sectional study at the outpatient clinic for long-term effects

Scandinavian Journal of Primary Health Care
Background After COVID-19 infection, long-term impacts on functioning may occur. We studied the functioning of patients with post-COVID-19 condition (PCC) and compared them to controls without PCC.Methods This cross-sectional study consisted of 442 ...
Sanna Stålnacke, Helena Liira, Velina Vangelova-Korpinen, Hélène Virrantaus, Mari Kanerva, Kirsi Kvarnström, Markku Sainio, Antti Malmivaara, Aki Vuokko, Mikko Varonen, Mikko Venäläinen, Jari Arokoski   +11 more
doaj   +1 more source

Symptom control

Gaceta Médica de México
In addition to symptoms secondary to splenomegaly, microvascular abnormalities, and thrombohemorrhagic complications, patients with MPN may experience a significant symptom burden attributed to an increase in circulating inflammatory cytokines. These symptoms can be severe and limit quality of life.
Gilberto, Barranco-Lampón, Raúl, Martínez-Castro, Luara, Arana-Luna, José Luis, Álvarez-Vera, Flavio, Rojas-Castillejos, Rosalinda, Peñaloza-Ramírez, Adrián Alejandro, Carballo-Zarate, Irma, Olarte-Carrillo, Jaime Israel-García, Minamy, Javier, López-Salazar, Juan José, Navarrete, Arturo, Espinosa-Partida, Yanet, Ventura-Enríquez, Josué Isel, Ruiz-Contreras, Oyuky Gissell, Aguirre-Reyes, Irene, Anaya-Cuéllar, Jocelyn, Aguilar-Luévano, Hugo Francisco, Díaz-Ramírez, Wilfrido, Herrera-Olivares, José Antonio, Aguilar-Hidalgo, Luisa Ma, Alcívar-Cedeño, Álvaro, Hernández-Caballero, Lourdes Elena, Galaz-Cordero, José Antonio de la, Peña-Celaya, Pamela Elena, Báez-Islas, Ramón Alberto, Bates-Martín, Ana Ma de la Luz, Cano-León, Ma Eugenia, Espitia-Ríos, Diego, Barbosa, Javier, Morales-Adrián, Martín Jacobo, Pacheco, Nancy, Delgado-López, Yvette, Neme-Yunes, Alba Edna, Moralws-Hernández, Aldo, Mújica-Martínez, Alejandra Betsabé, Pérez-Lizardi, Karen Daniela, Pérez-Gómez, Gabriel, Barragán-Ibáñez, Adolfo, Martínez, Karen, Flores-Ordúñez, Paulina, Ramírez-Hoyos, Ma de Los Ángeles, Rosales-López, Brenda Lizeth, Acosta-Maldonado, Marco Alejandro, Jiménez-Ochoa, Katheryn Betsabé, Garzón-Velásquez, Eleazar, Hernández-Ruiz, Bosco Martín, McNally-Guillén, Erick Eduardo, Saucedo-Montes, Carolina, Aguilar-Andrade, Cindy Lissette, Vivas-Arteaga, Lidia Virginia, Guerra-Alarcón, Andrea Iracema, Milán-Salvatierra, Dafne Itzel, Campa-Monroy, Xóchitl, Cota-Rangel, Patricia, Estrada-Domínguez, Alinka Socorro, García-Camacho, Carolina, García-Castillo, Luisa Iztacihuatl, Banda-García, Vania, Rodríguez-Sánchez, Luis Antonio, Meillón-García, Elizabeth, Urbina-Escalante, Mario Alberto, Martínez-Ramírez, Sergio José, Loera-Fragoso, Jorge, Martínez-Coronel, Nidia, Zapata-Canto, Sue Cynthia, Gómez-Cortés, Jesús Emanuel, Medina-Coral, Liliana, Mójica-Balderas, Juan Manuel, Pérez-Zúñiga, Fernando Jacobo, Pérez, José Luis, López-Arroyo, Juan Francisco, Zazueta-Pozos, Eduardo, Romero-Martínez, Hilda, Romero-Rodelo, Ana Laura, Tapia-Enríquez, Emely Johanny, Soriano-Mercedes, Óscar, Salazar-Ramírez, Shendel Paulina, Vilchis-González, Fredy, Tepepa-Flores, Martha, Alvarado-Ibarra   +79 more
openaire   +2 more sources

Anxiety and depression symptoms and migraine: a symptom-based approach research

The Journal of Headache and Pain, 2017
BackgroundAnxiety and mood disorders have been shown to be the most relevant psychiatric comorbidities associated with migraine, influencing its clinical course, treatment response, and clinical outcomes.
M. F. Peres, J. Mercante, P. Tobo, H. Kamei, M. Bigal   +4 more
semanticscholar   +1 more source

Deciphering transcriptomic changes in chemobrain: a comprehensive review

Acta Neuropathologica Communications
Chemotherapy-induced cognitive impairments (CICI), colloquially known as “chemobrain,” represents a profound and debilitating side effect experienced by a significant number of cancer survivors, impacting their memory, multitasking, and quality of life ...
Tusar Kanta Acharya, Yuan Pan, Peter M. Grace, Cobi J. Heijnen, Rajasekaran Mahalingam   +4 more
doaj   +1 more source

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa, Daisuke Honda, Seigo Akari, Tadao Akizawa   +3 more
wiley   +1 more source

Malnutrition Risk and the Psychological Burden of Anorexia and Cachexia in Patients With Advanced Cancer

JCSM Communications
Background Patients with advanced cancer are at risk for malnutrition and anorexia‐cachexia syndrome. The study objective was to determine the frequency of these conditions in patients evaluated in an outpatient supportive care clinic (SCC).
Rony Dev, Patricia Bramati, Marvin Omar Delgado Guay, Bryan Fellman, Ahsan Azhar, Michael Tang, Jegy Tennison, Josue Becerra, Sonal Admane, Shalini Dalal, David Hui, Egidio Del Fabbro, Eduardo Bruera   +12 more
doaj   +1 more source

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)

Journal of Patient-Reported Outcomes, 2019
Background Symptom assessment requires psychometrically validated questionnaires that are easy to use, relevant to the disease, and quick to administer. The MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM) was adapted from the
Tito R. Mendoza, Loretta A. Williams, Karen N. Keating, Jonathan Siegel, Cem Elbi, Anna K. Nowak, Raffit Hassan, Brian Cuffel, Charles S. Cleeland   +8 more
doaj   +1 more source